Putnam Investments LLC Eagle Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $54,187 - $96,643	2,051 Added 22.96%	10,984 $290,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $4,456 - $5,545	-108 Reduced 1.19%	8,933 $397,000
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $29,021 - $34,242	-651 Reduced 6.72%	9,041 $448,000
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $444,087 - $551,474	9,692 New	9,692 $493,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.